CYSTINOSIS RESEARCH FOUNDATION: Form 990, tax year 2021

View the entire original 990 at ProPublica ↗

Organization
CYSTINOSIS RESEARCH FOUNDATION (EIN 32-0067668)
Tax period
2021-07-01 to 2022-06-30
Filed
2023-01-10
IRS object ID
202310129349303516
Schema version
2021v4.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2023-01-10T10:54:02-08:00ReturnTs
Tax Period End2022-06-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN954489850PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1Montgomery Glick & CompanyBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line123801 Calabasas Rd Ste 103AddressLine1Txt
CityCalabasasCityNm
State AbbreviationCAStateAbbreviationCd
ZIP91302ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2021-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN320067668EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1CYSTINOSIS RESEARCH FOUNDATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlCYSTBusinessNameControlTxt
Phone9492237610PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line119200 VON KARMAN AVENUE 920AddressLine1Txt
CityIRVINECityNm
State AbbreviationCAStateAbbreviationCd
ZIP92612ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonGEOFFREY STACKPersonNm
Person TitleTrusteePersonTitleTxt
Signature2023-01-10SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstGEOFFREYPersonFirstNm
Person LastSTACKPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonPETER MONTGOMERYPreparerPersonNm
PTINP01209820PTIN
Phone8189996967PhoneNum

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer2TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
Federated Assurance LevelFAL1FederatedAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2021TaxYr
Build TS2023-03-07 01:45:13ZBuildTS

Form 990 IRS990

US Address USAddress

FieldValueIRS element (for citing)
Address Line119200 VON KARMAN AVENUE 920AddressLine1Txt
CityIRVINECityNm
State AbbreviationCAStateAbbreviationCd
ZIP92612ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$3,589,447GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.cystinosisresearch.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2003FormationYr
Legal Domicile StateCALegalDomicileStateCd
Activity Or MissionCRFs mission is to support bench, clinical and translational research to find better treatments and a cure for cystinosis. CRF is dedicated to funding research that will improve the quality of life for those with cystinosis and to find a cure for this devastating disease.ActivityOrMissionDesc
Voting Members Governing Body17VotingMembersGoverningBodyCnt
Voting Members Independent21VotingMembersIndependentCnt
Total Employee1TotalEmployeeCnt
Total Volunteers5TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
PY Contributions Grants$3,658,065PYContributionsGrantsAmt
CY Contributions Grants$2,921,004CYContributionsGrantsAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$151,448PYInvestmentIncomeAmt
CY Investment Income$668,443CYInvestmentIncomeAmt
CY Other Revenue$0CYOtherRevenueAmt
PY Total Revenue$3,809,513PYTotalRevenueAmt
CY Total Revenue$3,589,447CYTotalRevenueAmt
PY Grants And Similar Paid$2,791,861PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$2,152,223CYGrantsAndSimilarPaidAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$67,912PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$70,511CYSalariesCompEmpBnftPaidAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$309,353CYTotalFundraisingExpenseAmt
PY Other Expenses$611,067PYOtherExpensesAmt
CY Other Expenses$849,979CYOtherExpensesAmt
PY Total Expenses$3,470,840PYTotalExpensesAmt
CY Total Expenses$3,072,713CYTotalExpensesAmt
PY Revenues Less Expenses$338,673PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$516,734CYRevenuesLessExpensesAmt
Total Assets BOY$10,349,578TotalAssetsBOYAmt
Total Assets EOY$10,168,657TotalAssetsEOYAmt
Total Liabilities BOY$1,867,136TotalLiabilitiesBOYAmt
Total Liabilities EOY$1,942,498TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$8,482,442NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$8,226,159NetAssetsOrFundBalancesEOYAmt
MissionCRF is committed to finding a cure through an aggressively funded research agenda. CRF awards research grants bi-annually to accelerate the research process and to ensure that there is never a gap in funding new cutting-edge research projects. CRF is dedicated to improving the quality of life for cystinosis patients and to finding better treatments, including a cure, for our adults and children living with cystinosis.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$2,565,114ExpenseAmt
DescEDUCATIONThe Cystinosis Research Foundation is dedicated to educating the cystinosis community, the public and the medical community about cystinosis to ensure early diagnosis and immediate and proper treatment.NATALIES WISHNatalies wish, To have my disease go away forever, was the driving force and inspiration that led to the establishment of the Cystinosis Research Foundation (CRF) in 2003. We knew at that moment that we needed to make every effort to make Natalies wish and the wish of others with cystinosis a reality.HISTORY AND RESEARCHCystinosis is a rare, metabolic, genetic disease that afflicts approximately 2,500 children and adults worldwide. CRF is increasingly focused on funding clinical and translational research which is crucial to finding new treatments and a cure for cystinosis. CRF is committed to prioritizing and aggressively supporting research that has the potential to significantly improve the quality of life for children and adults with cystinosis.RESEARCH GIVES US HOPEWe firmly believe that funding and supporting research gives us hope for a brighter future for those living with cystinosis. Hope allows us to live with cystinosis until the day a cure is found.Since 2003, the Cystinosis Research Foundation (CRF) has raised over $63 million and has become the leading provider of funds for cystinosis research throughout the world. CRF has strategically and aggressively invested millions of dollars into cystinosis research creating a thriving and collaborative global research community that has changed the course of cystinosis.From the beginning, all CRF operating costs have been privately underwritten, so 100 percent of all donations received by CRF go to support cystinosis research.We are pleased to announce that during the 12-month period ending June 30, 2022, CRF awarded 13 new grants totaling $2,827,107 for cystinosis research. The new grants bring us that much closer to better treatments and a cure.CRF awards grants to the best and brightest researchers in the world. To date, CRF has funded 220 studies at leading research institutions in 12 countries. CRF-funded researchers have published 102 articles in prestigious, top-rated journals. Those articles, available to everyone in the world, have contributed to the understanding of the pathogenesis and treatment of cystinosis.RESEARCH PROGRESSFrom the start of the foundation, we have understood that funding basic and bench research was important to understanding cystinosis. Over the years, as discoveries were made in the lab, CRF began funding clinical research, and now we are translating the data from the clinical studies to the patients.Our strategy of providing seed money to talented researchers has been successful. Our first project involved funding researchers who were focused on a new treatment. CRF provided grants that funded every bench and clinical trial that led to the discovery of a delayed-release form of the life-saving medication for cystinosis. That medication, Procysbi was approved by the FDA on April 30, 2013, and is considered the most significant advancement in the treatment of cystinosis in 30 years.In 2007, CRF began funding Dr. Stphanie Cherqui, at UC San Diego who was focused on stem cell and gene therapy research. As a direct result of CRFs early and continuous funding, in December 2018, the FDA approved a clinical trial to assess the efficacy and safety of a stem cell and gene therapy treatment for cystinosis patients. In October 2019, the first cystinosis patient received the stem cell gene therapy treatment. In 2020, two patients received the therapy, in November 2021, the fourth patient received the treatment and in March 2022, the fifth patient received the treatment. The sixth and final patient in the phase 1/2 of the trial should be treated in 2022. The grants awarded to Dr. Cherqui for her stem cell work have been leveraged by multi-million-dollar grants from other funding agencies. If this treatment works, it could stop the progression of cystinosis or be the cure for cystinosis.Since cystinosis is a systemic disease and affects every cell, CRF has targeted multiple areas of research to fund including kidney disease, muscle wasting, neurological issues, corneal cystinosis, and stem cell and gene therapy, all with the goal of finding better treatments and a cure for cystinosis.CYSTINOSIS RESEARCH HELPS OTHERSMany of the discoveries made by CRF researchers are currently being applied to other more prevalent and well-known disorders and diseases including other corneal diseases, kidney diseases and genetic and systemic diseases similar to cystinosis. Support for cystinosis research has reached far beyond the cystinosis community. A cure for cystinosis will help find cures for other diseases potentially helping millions of people.CRF FAMILIES AND PARTNERSThe Cystinosis Research Foundation has witnessed tremendous growth over the years as cystinosis families have joined our fundraising efforts. People from all over the world have embraced the cystinosis cause and have enthusiastically raised funds to support cystinosis research through CRF. We have found strength in numbers and our joint effort gives us a renewed sense of community and purpose.DAY OF HOPE CONFERENCEEach year the Cystinosis Research Foundation hosts the Day of Hope Family Conference. In 2022, 36 families from around the world gathered to share their stories, hopes and dreams and to build life-long friendships. Leading CRF funded researchers attended the conference and updated the cystinosis community on their research progress including updates on gene and stem cell therapies, novel eye research and neurological research. The conference educates cystinosis families about current and ongoing research and offers them hope that brighter days are ahead for cystinosis patients. The 2020 and 2021 conferences were cancelled because of the pandemic.CURE CYSTINOSIS INTERNATIONAL REGISTRYThe Cystinosis Research Foundation is excited to announce that a new, updated registry, the Cure Cystinosis International Registry (CCIR) was launched in April 2021. Today, more than 156 cystinosis families have registered with CCIR. The new registry will track patients natural history data, collect data about current treatments, identify known and unknown medical complications and collect information about quality-of-life issues. The CCIR will be a central hub of information for the global community. The deidentified patient data from the registry can be shared with cystinosis clinicians, researchers and scientists who are pursuing research focused on better treatments and a cure for cystinosis.CRF INTERNATIONAL RESEARCH SYMPOSIUMCRFs International Research Symposium is held every two years and is a highlight for cystinosis researchers. Attendees are CRF funded researchers and scientists from around the world. Approximately 65 cystinosis experts from leading international universities and research institutions are invited to give presentations about their work. Attendees share their research progress and are encouraged to form collaborations in an effort to accelerate the research process. The symposium has created a synergistic research community working in partnership with CRF. The symposium was cancelled during the pandemic but will resume in 2023.Desc
Total Program Service Expenses$2,565,114TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesfalseLobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Donor Rstr Or Quasi EndowmentsfalseDonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesfalseReportOtherLiabilitiesInd
Include FIN48 FootnotefalseIncludeFIN48FootnoteInd
Independent Audit Fincl StmtfalseIndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtfalseConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgYes (true)MoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredfalseScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntfalseBusinessRlnWith35CtrlEntInd
Deductible Non Cash ContrifalseDeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document8IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee1EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsfalseQuidProQuoContributionsInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Form8282 Filed0Form8282FiledCnt
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Form8899 FiledindfalseForm8899Filedind
Form1098 C FiledfalseForm1098CFiledInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members17GoverningBodyVotingMembersCnt
Independent Voting Member21IndependentVotingMemberCnt
Family Or Business RlnYes (true)FamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOfalseCompensationProcessCEOInd
Compensation Process OtherfalseCompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonGEOFFREY STACKPersonNm
Phone9497565959PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line119200 VON KARMAN AVENUE STE 920AddressLine1Txt
CityIRVINECityNm
State AbbreviationCAStateAbbreviationCd
ZIP92612ZIPCd
FieldValueIRS element (for citing)
No Listed Persons CompensatedYes (X)NoListedPersonsCompensatedInd

Form990 Part VII Section A Form990PartVIISectionAGrp (17 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmt
NANCY J STACK
CHAIR - TRUSTEE40.000.00Yes (X)Yes (X)$0$0$0
GEOFFREY STACK
VICE CHAIR-TTEE0.000.00Yes (X)Yes (X)$0$0$0
DONALD L SOLSBY
TREASURER - TTE2.000.00Yes (X)Yes (X)$0$0$0
MARCU ALEXANDER
Trustee0.000.00Yes (X)$0$0$0
STEPHANIE CHERQUI PHD
Trustee0.000.00Yes (X)$0$0$0
BRUCE CRAIR
Trustee0.000.00Yes (X)$0$0$0
JILL EMERSON CPA
Trustee0.000.00Yes (X)$0$0$0
DENICE FLERCHINGER
Trustee0.000.00Yes (X)$0$0$0
ANGELA KIRCHHOF
Trustee0.000.00Yes (X)$0$0$0
LAUREN HARTZ
Trustee0.000.00Yes (X)$0$0$0
STEPHEN L JENKINS
Trustee0.000.00Yes (X)$0$0$0
ERIN LITTLE
Trustee0.000.00Yes (X)$0$0$0
DAVID W MOSSMAN
Trustee0.000.00Yes (X)$0$0$0
KEVIN PARTINGTON
Trustee0.000.00Yes (X)$0$0$0
TERESA PARTINGTON
Trustee0.000.00Yes (X)$0$0$0
BRIAN STURGIS
Trustee0.000.00Yes (X)$0$0$0
BARBARA KULYK
Trustee0.000.00Yes (X)$0$0$0
FieldValueIRS element (for citing)
Indiv Rcvd Greater Than100 K0IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KfalseTotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd
Cntrct Rcvd Greater Than100 K0CntrctRcvdGreaterThan100KCnt
Fundraising$336,494FundraisingAmt
All Other Contributions$2,584,510AllOtherContributionsAmt
Total Contributions$2,921,004TotalContributionsAmt
Total Program Service Revenue$0TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$217,021TotalRevenueColumnAmt
Related Or Exempt Func Income$217,021RelatedOrExemptFuncIncomeAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$451,422SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$451,422SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$451,422TotalRevenueColumnAmt
Related Or Exempt Func Income$451,422RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Contri Rpt Fundraising Event$366,494ContriRptFundraisingEventAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Other Revenue Total$0OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$3,589,447TotalRevenueColumnAmt
Related Or Exempt Func Income$668,443RelatedOrExemptFuncIncomeAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$1,144,436TotalAmt
Program Services$1,144,436ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$1,007,787TotalAmt
Program Services$1,007,787ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$65,577TotalAmt
Program Services$12,386ProgramServicesAmt
Management And General$48,562ManagementAndGeneralAmt
Fundraising$4,629FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$4,934TotalAmt
Program Services$938ProgramServicesAmt
Management And General$3,651ManagementAndGeneralAmt
Fundraising$345FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$7,585TotalAmt
Program Services$5,981ProgramServicesAmt
Management And General$1,604ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$101,508TotalAmt
Program Services$14,478ProgramServicesAmt
Management And General$72,320ManagementAndGeneralAmt
Fundraising$14,710FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$110,080TotalAmt
Fundraising$110,080FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$17,889TotalAmt
Management And General$17,889ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$10,324TotalAmt
Management And General$10,324ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtFundraisingFundraisingAmtManagement And GeneralManagementAndGeneralAmt
EDUCATION$255,245$255,245
MAGAZINE$126,517$57,076$69,441
OUTSIDE SERVICES$86,413$66,660$13,618$6,135
AUCTION ITEMS$61,671$61,671

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$72,747TotalAmt
Program Services$127ProgramServicesAmt
Management And General$37,761ManagementAndGeneralAmt
Fundraising$34,859FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$3,072,713TotalAmt
Program Services$2,565,114ProgramServicesAmt
Management And General$198,246ManagementAndGeneralAmt
Fundraising$309,353FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$5,968,759BOYAmt
EOY$6,158,524EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$600,684BOYAmt
EOY$30,933EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$89,502BOYAmt
EOY$89,886EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$162,197LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$109,298LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$70,788BOYAmt
EOY$52,899EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$3,619,845BOYAmt
EOY$3,836,415EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$10,349,578BOYAmt
EOY$10,168,657EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$17,794BOYAmt
EOY$31,040EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$1,849,342BOYAmt
EOY$1,911,458EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$1,867,136BOYAmt
EOY$1,942,498EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$8,482,442BOYAmt
EOY$8,226,159EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$8,482,442BOYAmt
EOY$8,226,159EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$10,349,578BOYAmt
EOY$10,168,657EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$516,734ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$773,017NetUnrlzdGainsLossesInvstAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$4,095,889CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,347,869CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$4,064,820CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$3,658,065CurrentTaxYearMinus1YearAmt
Current Tax Year$2,921,004CurrentTaxYearAmt
Total$20,087,647TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$4,095,889CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,347,869CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$4,064,820CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$3,658,065CurrentTaxYearMinus1YearAmt
Current Tax Year$2,921,004CurrentTaxYearAmt
Total$20,087,647TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$0SubstantialContributorsTotAmt
Public Support Total170$20,087,647PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$86,549CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$54,850CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$243,604CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$151,448CurrentTaxYearMinus1YearAmt
Current Tax Year$668,443CurrentTaxYearAmt
Total$1,204,894TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt
FieldValueIRS element (for citing)
Total Support$21,292,541TotalSupportAmt
Public Support CY1700.94340PublicSupportCY170Pct
Public Support PY1700.97450PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$8,874OtherCostOrOtherBasisAmt
Depreciation$3,625DepreciationAmt
Book Value$5,249BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$106,488OtherCostOrOtherBasisAmt
Depreciation$85,801DepreciationAmt
Book Value$20,687BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$46,835OtherCostOrOtherBasisAmt
Depreciation$19,872DepreciationAmt
Book Value$26,963BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$52,899TotalBookValueLandBuildingsAmt

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (10 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
BELGIUM00GRANTSMEDICAL RESEARCH$0
BELGIUM00GRANTSMEDICAL RESEARCH$0
ITALY00GRANTSMEDICAL RESEARCH$225,500
SWITZERLAND00GRANTSMEDICAL RESEARCH$196,090
NEW ZEALAND00GRANTSMEDICAL RESEARCH$0
FRANCE00GRANTMEDICAL RESEARCH$265,000
ITALY00GRANTSMEDICAL RESEARCH$0
FRANCE00GRANTSMEDICAL RESEARCH$139,323
FRANCE00GRANTSMEDICAL RESEARCH$0
ITALY00GRANTSMEDICAL RESEARCH$181,874
FieldValueIRS element (for citing)
Subtotal Spent$1,007,787SubtotalSpentAmt
Total Spent$1,007,787TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (10 entries)

Purpose Of GrantPurposeOfGrantTxtManner Of Cash DisbursementMannerOfCashDisbursementTxt
MEDICAL RESEARCHCHECK
MEDICAL RESEARCHCHECK
MEDICAL RESEARCHCHECK
MEDICAL RESEARCHCHECK
MEDICAL RESEARCHCHECK
MEDICAL RESEARCHCHECK
MEDICAL RESEARCHCHECK
MEDICAL RESEARCHCHECK
MEDICAL RESEARCHCHECK
MEDICAL RESEARCHCHECK
FieldValueIRS element (for citing)
Total501c3 Org5Total501c3OrgCnt
Total Other Org5TotalOtherOrgCnt
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Special Fundraising EventsYes (X)SpecialFundraisingEventsInd
Agrmt Prof Fundraising ActyfalseAgrmtProfFundraisingActyInd
Licensed StatesCALicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1ANNUAL FUNDRAISER - SEE NOTE (4)Event1Nm
Gross Receipts Event1$366,494GrossReceiptsEvent1Amt
Charitable Contri Event1$366,494CharitableContriEvent1Amt
Gross Receipts Total$366,494GrossReceiptsTotalAmt
Charitable Contributions Tot$366,494CharitableContributionsTotAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (3 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtPurpose Of GrantPurposeOfGrantTxt
THE SCRIPPS INSTITUTE
10550 N TORREY PINES ROADLA JOLLACA92037330435954$234,279$0MEDICAL RESEARCH
UNIVERSITY OF CALIFORNIA SD
9500 GILMAN DRIVE DEPT 0935LA JOLLACA92093956006144$626,667$0MEDICAL RESEARCH
UNIVERSITY OF WASHINGTON
PO BOX 359505SEATTLEWA98195943079432$283,490$0MEDICAL RESEARCH
FieldValueIRS element (for citing)
Total501c3 Org3Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp

Name Of Interested NameOfInterested

FieldValueIRS element (for citing)
PersonZOE SOLSBYPersonNm
FieldValueIRS element (for citing)
Relationship DescriptionWIFE OF OFFICERRelationshipDescriptionTxt
TransactionCOMPENSATIONTransactionDesc
Sharing Of RevenuesfalseSharingOfRevenuesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule L, Part V Supplemental InformationFormAndLineReferenceDesc
ExplanationSEE NOTE 1 TO SCHEDULE LExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Statement Note 1NOTE (2) - FUNDRAISERSSCHEDULE G - PART II THE FOUNDATION HOLDS ANNUAL FUNDRAISING EVENTS. HOWEVER THE INCOME IS RECEIVED IN THE FORM OF CHARITABLE CONTRIBUTIONS AND SO NO SEPARATE ACCOUNTING HAS BEEN SHOWN ON SCHEDULE G. DIRECT COSTS OF THE FUNDRAISERS ARE SHOWN ON FORM 990, PART IX. CONTROL OF FUNDS IS MAINTAINED BY THE FOUNDATION AND NOT THIRD PARTY PROFESSIONAL FUNDRAISERS.
Form 990, Part VI, Line 2: Description of Business or Family Relationship of Officers, Directors, EtTRUSTEES, GEOFFREY AND NANCY STACK,ARE HUSBAND AND WIFE. BOARD MEMBERS, KEVIN AND TERESA PARTINGTON, ARE HUSBAND AND WIFE.
Form 990, Part VI, Line 11b: Form 990 Review ProcessFORM 990 IS REVIEWED BY BOARD OF DIRECTORS PRIOR TO FILING. AUDITORS FOR THE FOUNDATION HAVE REVIEWED THE RETURN AND PROVIDED COMMENTS TO THE TAX PREPARER.
Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of ConflictsBOARD REVIEWS POSSIBLE CONFLICTS ON AN AS NEEDED BASIS AND DISCUSSES RESOLUTIONS AT BOARD MEETINGS
Form 990, Part VI, Line 19: Other Organization Documents Publicly AvailableCRF MAINTAINS THE GOVERNING DOCUMENTS, POLICIES AND PROCEDURES AND FINANCIAL STATEMENTS AT ITS OFFICES IN IRVINE, CALIFORNIA. COPIES OF THESE DOCUMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. OUR FORM 990 IS POSTED ON OUR WEBSITE AND ON GUIDESTAR ON THE INTERNET.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.